Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02144649 · ClinicalTrials.gov registry record · NA
Tangerine or Red Tomato Juice in Treating Patients With Prostate Cancer Undergoing Surgery
A NA study, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT02144649 is a NA study that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 45 participants.
The verdict
NCT02144649, a NA study, has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
This randomized pilot clinical trial compares tangerine and red tomato juice in treating patients with prostate cancer undergoing surgery. A diet high in lycopene, a substance found in tomatoes, may help prevent normal cells from transforming into cancer cells in patients with prostate cancer.
Interventions
- OTHER questionnaire administration
- OTHER Correlative studies
- DIETARY_SUPPLEMENT dietary intervention (tangerine tomato juice)
- DIETARY_SUPPLEMENT dietary intervention (red tomato juice)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2015-06 |
| Est. Completion | 2016-09-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02144649
The ClinicalTrials.gov registry entry for NCT02144649 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which questionnaire administration is the first listed.
NCT02144649 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02144649 about?
NCT02144649 is a clinical study titled "Tangerine or Red Tomato Juice in Treating Patients With Prostate Cancer Undergoing Surgery". This randomized pilot clinical trial compares tangerine and red tomato juice in treating patients with prostate cancer undergoing surgery. A diet high in lycopene, a substance found in tomatoes, may help prevent normal cells from transforming into cancer cells in patients with prostate cancer.
What is the current status of trial NCT02144649?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2015-06. Estimated completion is 2016-09-22.
What interventions are being tested in trial NCT02144649?
The interventions under investigation include: questionnaire administration (OTHER), Correlative studies (OTHER), dietary intervention (tangerine tomato juice) (DIETARY_SUPPLEMENT), dietary intervention (red tomato juice) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02144649?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.